AI Portfolio Summary
In 2015 Q4, Bellevue Asset Management AG maintained a portfolio of 140 distinct positions. They heavily accumulated shares in Biogen Inc., increasing their position by 17.1%. Conversely, Bellevue Asset Management AG completely exited their position in Allergan PLC.
Total Positions
140
Quarter
2015 Q4
Top Holding
CELG (4.0%)
Top 10 Concentration
31.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 140
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CELG
Celgene Corpora...
|
Unknown | 3.97% | 4.05% |
#1
1
Prev: #2
|
4.1 | -12,350 | -5.4% |
P
S
|
217,410 | $26,037,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
BIIB
Biogen Inc.
|
Healthcare | 3.92% | 3.42% |
#2
1
Prev: #3
|
5.1 | 12,260 | 17.1% |
P
S
|
84,030 | $25,743,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
GILD
Gilead Sciences...
|
Healthcare | 3.70% | 4.07% |
#3
2
Prev: #1
|
3.0 | -13,930 | -5.5% |
P
S
|
240,120 | $24,298,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
AMGN
Amgen Inc.
|
Healthcare | 3.04% | 2.71% |
#4
3
Prev: #7
|
2.2 | 3,000 | 2.5% |
P
S
|
123,000 | $19,967,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
REGN
Regeneron Pharm...
|
Healthcare | 3.01% | 2.95% |
#5
Prev: #5
|
2.2 | -2,500 | -6.4% |
P
S
|
36,400 | $19,760,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
MDT
Medtronic, Inc.
|
Healthcare | 3.01% | 2.95% |
#6
Prev: #6
|
1.7 | -13,500 | -5.0% |
P
S
|
256,500 | $19,730,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
ILMN
Illumina, Inc.
|
Healthcare | 2.67% | 2.51% |
#7
1
Prev: #8
|
1.6 | 3,800 | 4.3% |
P
S
|
91,425 | $17,549,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
ABT
Abbott Laborato...
|
Healthcare | 2.61% | 3.04% |
#8
4
Prev: #4
|
1.5 | -81,500 | -17.6% |
P
S
|
381,500 | $17,133,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
MYL
Mylan Inc.
|
Unknown | 2.60% | 1.48% |
#9
7
Prev: #16
|
3.5 | 90,300 | 40.1% |
P
S
|
315,300 | $17,048,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
BDX
Becton, Dickins...
|
Healthcare | 2.47% | 2.00% |
#10
3
Prev: #13
|
3.0 | 12,770 | 13.8% |
P
S
|
105,075 | $16,191,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
CAH
Cardinal Health...
|
Healthcare | 2.33% | 1.00% |
#11
25
Prev: #36
|
3.9 | 91,480 | 114.3% |
P
S
|
171,480 | $15,308,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
UNH
UnitedHealth Gr...
|
Healthcare | 2.15% | 2.27% |
#12
3
Prev: #9
|
1.9 | no change | no change |
P
S
|
120,000 | $14,117,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
SYK
Stryker Corpora...
|
Healthcare | 1.99% | 2.16% |
#13
2
Prev: #11
|
1.8 | no change | no change |
P
S
|
140,700 | $13,077,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
TEVA
Teva Pharmaceut...
|
Healthcare | 1.77% | 1.56% |
#14
1
Prev: #15
|
1.2 | 7,500 | 4.4% |
P
S
|
176,720 | $11,600,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
ESRX
Express Scripts...
|
Unknown | 1.65% | 2.11% |
#15
3
Prev: #12
|
0.7 | -36,000 | -22.5% |
P
S
|
124,000 | $10,839,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
ENDP
Endo Internatio...
|
Unknown | 1.60% | 1.79% |
#16
2
Prev: #14
|
2.6 | 13,000 | 8.2% |
P
S
|
171,000 | $10,469,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
N/A
Auris Medical H...
|
—
|
Unknown | 1.59% | 1.26% |
#17
7
Prev: #24
|
1.6 | no change | no change |
P
S
|
2,169,625 | $10,414,000 | — | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | ||
|
ZBH
Zimmer Holdings...
|
Healthcare | 1.49% | 1.46% |
#18
1
Prev: #17
|
1.6 | no change | no change |
P
S
|
95,500 | $9,797,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
ALXN
Alexion Pharmac...
|
Unknown | 1.44% | 1.26% |
#19
4
Prev: #23
|
1.6 | no change | no change |
P
S
|
49,400 | $9,423,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
CVS
CVS Health Corp...
|
Healthcare | 1.43% | 0.87% |
#20
22
Prev: #42
|
3.6 | 41,200 | 74.9% |
P
S
|
96,200 | $9,405,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
LGND
Ligand Pharmace...
|
Healthcare | 1.35% | 1.34% |
#21
Prev: #21
|
1.0 | -14,090 | -14.7% |
P
S
|
81,640 | $8,851,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
INCY
Incyte Corporat...
|
Healthcare | 1.31% | 1.39% |
#22
3
Prev: #19
|
1.0 | 2,000 | 2.6% |
P
S
|
79,000 | $8,568,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
IONS
Ionis Pharmaceu...
|
Healthcare | 1.30% | 0.87% |
#23
18
Prev: #41
|
1.0 | 6,000 | 4.5% |
P
S
|
138,000 | $8,546,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
BSX
Boston Scientif...
|
Healthcare | 1.29% | 1.07% |
#24
7
Prev: #31
|
2.5 | 60,000 | 15.0% |
P
S
|
460,000 | $8,482,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
MCK
McKesson Corpor...
|
Healthcare | 1.29% | 1.24% |
#25
1
Prev: #26
|
1.0 | 2,000 | 4.9% |
P
S
|
43,000 | $8,481,000 | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
N/A
Allergan PLC
|
—
|
Unknown | 0.00% | 2.22% |
Sold All 😨
(Was: #10) |
0.0 | -50,150 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | ||
|
RDY
Dr. Reddy's Lab...
|
Healthcare | 0.00% | 1.36% |
Sold All 😨
(Was: #20) |
0.0 | -130,000 | -100.0% |
CLOSED
|
— | $— | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
AKRX
Akorn, Inc.
|
Unknown | 0.00% | 0.52% |
Sold All 😨
(Was: #58) |
0.0 | -112,470 | -100.0% |
CLOSED
|
— | $— | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
ZFGN
Zafgen Inc.
|
Unknown | 0.00% | 0.52% |
Sold All 😨
(Was: #59) |
0.0 | -100,000 | -100.0% |
CLOSED
|
— | $— | 2015 Q3 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
XRAY
DENTSPLY Intern...
|
Healthcare | 0.00% | 0.48% |
Sold All 😨
(Was: #63) |
0.0 | -58,400 | -100.0% |
CLOSED
|
— | $— | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
N/A
Ultra NASDAQ Bi...
|
—
|
Unknown | 0.00% | 0.33% |
Sold All 😨
(Was: #84) |
0.0 | -35,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | ||
|
N/A
iKang Healthcar...
|
—
|
Unknown | 0.00% | 0.18% |
Sold All 😨
(Was: #102) |
0.0 | -75,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | ||
|
N/A
Endologix, Inc.
|
—
|
Unknown | 0.00% | 0.10% |
Sold All 😨
(Was: #117) |
0.0 | -50,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | ||
|
PEN
Penumbra Inc.
|
Healthcare | 0.00% | 0.07% |
Sold All 😨
(Was: #121) |
0.0 | -10,000 | -100.0% |
CLOSED
|
— | $— | 2015 Q3 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
DYAX
Dyax Corporatio...
|
Unknown | 0.00% | 0.05% |
Sold All 😨
(Was: #123) |
0.0 | -15,000 | -100.0% |
CLOSED
|
— | $— | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
THRX
Theravance, Inc...
|
Unknown | 0.00% | 0.04% |
Sold All 😨
(Was: #124) |
0.0 | -35,000 | -100.0% |
CLOSED
|
— | $— | 2015 Q1 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | |||
|
N/A
Rewalk Robotics...
|
—
|
Unknown | 0.00% | 0.04% |
Sold All 😨
(Was: #125) |
0.0 | -30,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) | ||
|
BTX
Biotime Inc.
|
Financial Services | 0.00% | 0.00% |
Sold All 😨
(Was: #133) |
0.0 | -2,294 | -100.0% |
CLOSED
|
— | $— | 2015 Q3 | 13F Filing | 2015-12-31 | 2016-02-14 (Est.) |
Showing 1-25 of 140 holdings